Di-D-fructose-2,6':6,2'-dianhydride (DFA-IV) is a disaccharide consisting of two fructose residues that are prepared from levan by levan fructotransferase. Levan is a homopolysaccharide composed of D-fructofuranosyl residues joined by β-(2,6) and β-(2,1) linkages. We compared the immunomodulatory effects of levan with DFA-IV. Tumoricidal activity, phagocytosis and nitric oxide (NO) production were examined in levan-and DFA-IV-treated RAW264.7 cells. The NO production, tumoricidal and phagocytic activities were significantly increased in both treated cells. The results indicate that levan has significantly greater effects on tumoricidal activity than DFA-IV at low concentrations (1 µg/mL) and its effect on NO production shows a similar pattern. These results suggest that tumoricidal activity induced by both samples is mediated by NO production.
INTRODUCTION
Levans are natural homopolysaccharides composed of D-fructofuranosyl residues joined by β-(2,6) and β-(2,1) linkages. Low-molecular-weight (2 kDa～60 MDa) levans are produced in plants as carbohydrate reserves (1) . Their molecular structure is a short linear chain of β-(2→ 6)-fructose. In microorganisms, levans have higher molecular weights and generally extensive branching through β-(2→1) linkages are present in addition to the β-(2→6) linkages seen in levans of plants. Di-D-fructose-2,6': 6,2'-dianhydride (DFA-IV) is a disaccharide consisting of two fructose residues which can be synthesized chemically or enzymatically from fructans, inulin and levanall naturally occurring fructose homopolysaccharides (1, 2) . Five kinds of difructose dianhydrides (DFA I-V) have been found. DFA II and V can be synthesized only by chemical processes, while the others can be produced enzymatically (2) . DFA-I and III are produced from inulin by the action of inulin fructotransferase and DFA-IV is produced from levan by the action of levan fructotransferase (LFTase). However, production of microbial levan and DFA-IV is problematic because the purification from the culture broth is difficult due to its high viscosity and the use of large amounts of organic solvent (3) . Recently, it has been reported that DFA-IV could be produced from levan by the reaction of LFTase from Arthrobacter oxydans J17-21 by means of LFTase gene cloning from A. ureafaciens K2032 (4-6). It has been reported that levan strongly induces IL-12 and TNF-α in macrophages (7) . Although DFA-IV is a derivative of levan, published scientific information regarding its immunomodulation activity is scarce.
Macrophages have been shown to be an important component of host defense against bacterial infection and cancer (8, 9) . Large pools of macrophages, thought to be of mononuclear phagocyte origin, are located throughout the body and historically have been identified by different names according to their location in the body, including peritoneum (peritoneal macrophages), brain (microglia), bone (osteoclast) and liver (Kupffer cells). This host wide system of macrophages undergoes developmental changes in response to various signals in which they acquire or increase some functions and lose or decrease others. Four general stages of activation have been defined and cells in these stages are called resident, inflammatory (or responsive), primed and fully activated macrophages (10, 11) in the murine system. When exposed in vitro IFN-γ and LPS, inflammatory macrophages can develop the capacity to kill tumor cells, and these stages are called fully activated macrophages.
During sequential development through the various stages, macrophages increase in phagocytic activity and release various materials such as cytokines and reactive intermediates and then carry out nonspecific immune responses (10, 12) . Especially, there has been great interest in the reactive nitrogen intermediate, nitric oxide (NO) which is considered to be a central molecule in the regulation of the immune response to tumors because of its cytotoxic effects (13) (14) (15) . It is known that inducible nitric oxide synthase (iNOS) is expressed in many different cell types and increased iNOS enzymes produces high levels of NO (14, 15) . In the present study, we investigated the comparative immunomodulatory effects of DFA-IV and levan on tumoricidal and phagocytic activities of macrophages.
MATERIALS AND METHODS
Preparation of levan and DFA-IV Bacterial levan (MW 6 × 10 6 Da) from Zymomonas mobilis was prepared as described previously (16) and obtained from RealBioTech Co. Ltd. (Daejon, Korea). DFA-IV was synthesized from levan using LFTase as described previously (4) and obtained from RealBioTech Co. Ltd., respectively.
Cell culture RAW264.7 (mouse leukaemic monocyte macrophage cell line) and B16 (murine melanoma cell line) were obtained from ATCC (Manassas, VA). The cells were maintained in RPMI 1640 medium (Cambrex, Walkersville, MD) supplemented with 10% fetal bovine serum (Cambrex) and 2% Penicillin/streptomycin (Cambrex) and incubated at 37 o C in 5% CO 2 .
MTT assay for cell viability
Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described previously (17) . Briefly, the cells were seeded in 96-well plates at density of 5 × 10 4 cells per well and incubated with various concentrations of two samples for 24 h. The cells were washed once with D-PBS and 200 μL of MTT solution (25 μg/mL in media) was added to each well. After incubation at 37 o C under 5% CO 2 for 4 h, the MTT solution was carefully discarded and the formazan blue crystals formed by the reduction of MTT was dissolved in 150 μL DMSO. The amount of formazan was determined by absorbance at 540 nm using a microplate reader (Menlo Park, CA).
NBT assay for phagocytosis
Phagocytosis was measured by nitro blue tetrazolium (NBT) reduction assay as described previously (18) . The cells were seeded in 96-well plates at a density 5 × 10 4 cells per well and incubated with various concentrations of two samples for 24 h. The cultured media was then removed, and 50 μL of zymosan (5 × 10 6 particles/ml) and 0.6 mg/mL NBT were added to each well. After an additional incubation for 1 h, the cells were washed twice with cold D-PBS and the optical density of reduction product of NBT (a purple insoluble formazan) was determined at 540 nm using a microplate reader.
Nitrite determination
The cells were treated with various concentrations of two samples for 24 h and the accumulation of nitrite in culture supernatants was measured as described by Ding et al. (19) . 100 μL aliquots of culture supernatants were mixed with an equal volume of Griess reagent (mixture at 1:1 of naphthylethylenediamine dihydrochloride and 1% sulphanilamide in 5% H 3 PO 4 ) and incubated at room temperature for 10 min. Nitrite concentration was calculated from a NaNO 2 standard curve.
Macrophage-mediated tumoricidal activity
The assay for macrophage tumoricidal activity was based on an assay described elsewhere (17) . 
Western blot analysis
The amount of iNOS was measured by Western blot analysis. After 6 h of incubation with or without two samples, cells in six-well plates were lysed in sodium dodecylsulfate polyacrylamide gel electrophoresis buffer. Protein concentrations were measured using the DC Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA). Twenty micrograms of each sample was electrophoresed on 10% sodium dodecylsulfate polyacrylamide gel electrophoresis gels and transferred to Hybond-ECL nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ, USA). The membranes were blocked with 5% skim milk in Tris-buffered saline/non-fat Tween for 1 h. The membranes were incubated with primary antibody against iNOS for 24 h. They were then washed with Tris-buffered saline/non-fat Tween once for 15 min and three times for 5 min and incubated with secondary ALP-conjugated anti-rabbit antibody for 1 h. The membranes were washed again as described above. Autoradiography was carried out using an enhanced chemiluminescence kit (Amersham Bioscience).
Statistical analysis
The data is expressed as mean ± SE The statistical difference between the groups was determined using a one-way analysis of variance (ANOVA) with a Dunnett's t-test. A p value<0.05 was considered significant.
RESULTS AND DISCUSSIONS

Effects of levan and DFA-IV on cell viability
To determine the optimal concentrations of DFA-IV and levan for stimulating macrophages, we evaluated the proliferative effect of DFA-IV and levan on the cell viability of RAW264.7. As shown in Fig. 1 , DFA-IV and levan had no effect on cell viability. In addition, when the cells were treated with DFA-IV at 500 μg/mL for 24 h, cell cytotoxicity appeared (data not shown). Therefore, in all subsequent experiments DFA-IV and levan were used at 1 to 100 μg/mL for 24 h.
Effects of levan and DFA-IV on phagocytosis
Phagocytosis is the primary function of macrophages, which leads to enhance a diverse range of antimicrobial and cytotoxic responses including generation of respiratory bust, secretion of inflammatory mediators and antigen presentation. In this study, we examined the effects of DFA-IV and levan on phagocytosis of macrophages. When RAW264.7 cells were treated with various concentrations of DFA-IV or levan in the same concentration range (1～100 μg/mL) for 24 h, phagocytic activity was significantly increased (Fig. 2) . However, levan had no effects on phagocytic activity of macrophages at low concentrations (1 μg/mL). These results suggest that the two samples have different effects on phagocytosis of marophages depending on concentrations.
Effects of levan and DFA-IV on macrophage tumoricidal activity
To examine whether levan or DFA-IV treatment stimulates the tumoricidal activities of macrophages against target tumor cells, macrophages were co-cultured with B16 cells for 24 h. B16 tumor cells were used as the target since they are either TNF-α or NO sensitive. As shown in Fig. 3 , both levan and DFA-IV enhanced the tumoricidal activity of macrophages. However, levan had maximal effects on tumoricidal activity of macrophages at low concentrations (1 μg/mL). Similar patterns were observed in the accumulation of nitrites and iNOS gene expression in RAW264.7 cells treated with levan (Fig.  4(A), (C) ). In addition, our results showed that DFA-IV enhanced maximal tumoricidal activity of macrophages at 100 μg/mL, which was similar to that seen in LPS/IFN-γ-activated RAW264.7 cells that were used as a positive control (Fig. 3(B) ).
Effects of levan and DFA-IV on nitric oxide production and iNOS gene expression
Since NO is related to cytotoxic function of macrophages against a variety of tumors and microorganisms and is produced in high amounts by iNOS in activated macrophages (14, 15) , we examined the effects of levan and DFA-IV on both NO production and iNOS gene expression by assaying iNOS protein levels. As shown in Fig. 4 , the treatment of cells with levan or DFA-IV increased the production of NO and iNOS gene expression.
In the present study, our data demonstrate that levan and DFA-IV have immunomodulatory effects on tumoricidal activity and phagocytosis of macrophages. Moreover, levan and DFA-IV increased NO production and iNOS gene expression of macrophages.
Unexpectedly, levan maximally enhanced tumoricidal activity of macrophages at low concentrations (1 μg/ mL). Similar results were obtained for iNOS levels and NO production in levan-treated RAW264.7 cells. At the present time, we do not know why tumoricidal activity is less induced by levan at high concentrations. It is plausible that cells could be desensitized by levan at high concentrations and subsequently cause the modification of receptor molecules. However, in our system, our results suggest that the tumoricidal activity induced by levan or DFA-IV might be mediated by the production of NO.
It has been reported that levan produced by Aerobacter levanicum (20, 21) and Zymomonas mobilis (22, 23) , displayed anti-tumour and immunomodulatory effects. Xu et al. also suggested that levan might be related to the immunostimulatory activity of natto and levan suppressed allergic inflammation with IgE production (7) . In the present study, our data suggest that NO production as well as tumoricidal and phagocytotic activities were significantly increased in both levan-and DFA-IV-treated groups. Therefore, DFA-IV has immunomodulatory effects which are similar to those of levan, suggesting . Culture supernatants were collected and the levels of nitrite were measured as described in materials and method. The data represents the mean±SE of quadruplicate experiments. * p<0.05; significantly different from the control (no treatment). RAW264.7 were treated with two samples for 24 h. Total protein was extracted and subjected to Western blot analysis for iNOS and β-actin gene.
that DFA-IV could be a substitute for levan as a functional food, and as such have immunotherapeutic usefulness in cancer therapy.
